Emcure Pharmaceuticals Limited (NSE:EMCURE)

Emcure Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	338,124	302,490	203,202	-	-	-
Market Cap Growth	28.05%	48.86%	-	-	-	-
Enterprise Value	352,127	315,376	214,615	-	-	-
Last Close Price	1782.60	1592.40	1068.11	-	-	-

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	32.80	32.72	29.82	-	-	-
Forward PE	26.67	27.50	24.17	-	-	-
PS Ratio	3.49	3.29	2.57	-	-	-
PB Ratio	6.79	6.08	4.38	-	-	-
P/TBV Ratio	8.78	7.86	5.81	-	-	-
P/FCF Ratio	58.00	51.89	32.26	-	-	-
P/OCF Ratio	35.84	32.06	23.86	-	-	-
PEG Ratio	1.30	1.02	0.93	-	-	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	3.64	3.43	2.72	-	-	-
EV/EBITDA Ratio	18.49	18.31	15.20	-	-	-
EV/EBIT Ratio	23.99	22.96	19.79	-	-	-
EV/FCF Ratio	60.40	54.10	34.07	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.31	0.31	0.22	0.75	0.88	1.05
Debt / EBITDA Ratio	0.80	0.86	0.70	1.91	1.99	1.68
Debt / FCF Ratio	-	2.61	1.62	2.84	6.55	5.69
Net Debt / Equity Ratio	0.28	0.28	0.17	0.60	0.71	0.97
Net Debt / EBITDA Ratio	0.72	0.80	0.56	1.58	1.65	1.59
Net Debt / FCF Ratio	-	2.38	1.26	2.27	5.30	5.27
Asset Turnover	-	1.03	0.99	0.92	0.94	0.91
Inventory Turnover	-	1.68	1.80	1.66	1.54	1.47
Quick Ratio	-	0.71	0.86	0.75	0.72	0.51
Current Ratio	-	1.43	1.71	1.33	1.27	1.16
Return on Equity (ROE)	-	19.57%	18.23%	18.28%	23.59%	31.35%
Return on Assets (ROA)	-	9.62%	8.45%	7.92%	9.04%	10.54%
Return on Invested Capital (ROIC)	16.93%	17.04%	15.16%	13.97%	15.92%	18.40%
Return on Capital Employed (ROCE)	-	24.10%	19.50%	20.00%	25.20%	35.00%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	3.05%	3.06%	3.35%	-	-	-
FCF Yield	1.72%	1.93%	3.10%	-	-	-
Dividend Yield	0.21%	0.23%	0.28%	-	-	-
Payout Ratio	6.75%	6.15%	-	10.89%	6.80%	8.19%
Buyback Yield / Dilution	-0.24%	-1.33%	-3.41%	-0.01%	-	-
Total Shareholder Return	-0.04%	-1.11%	-3.13%	-0.01%	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error